PUBLIC LAW 116–22—JUNE 24, 2019  133 STAT. 951  vendor within 90 days of a determination by the Secretary to  renew, extend, or terminate such contract.’’.  Section 565(f) of the Federal Food, Drug, and Cosmetic Act  (21 U.S.C. 360bbb–4(f)) is amended—  (1) by redesignating paragraphs (3) through (6) as para- graphs (4) through (7), respectively;  SEC. 503. AVAILABILITY OF REGULATORY MANAGEMENT PLANS.  Web posting.  (2) by inserting after paragraph (2) the following:  ‘‘(3) PUBLICATION.—The Secretary shall make available on  the internet website of the Food and Drug Administration  information regarding regulatory management plans, including—  ‘‘(A) the process by which an applicant may submit  a request for a regulatory management plan;  ‘‘(B) the timeframe by which the Secretary is required  to respond to such request;  ‘‘(C) the information required for the submission of  such request;  ‘‘(D) a description of the types of development mile- stones and performance targets that could be discussed  and included in such plans; and  ‘‘(E) contact information for beginning the regulatory  management plan process.’’;  (3) in paragraph (6), as so redesignated, in the matter  preceding subparagraph (A)—  (A) by striking ‘‘paragraph (4)(A)’’ and inserting ‘‘para- graph (5)(A)’’; and  (B) by striking ‘‘paragraph (4)(B)’’ and inserting ‘‘para- graph (5)(B)’’; and  (4) in paragraph (7)(A), as so redesignated, by striking  ‘‘paragraph (3)(A)’’ and inserting ‘‘paragraph (4)(A)’’.  SEC. 505. ADDITIONAL STRATEGIES FOR COMBATING ANTIBIOTIC  RESISTANCE.  SEC. 504. THE BIOMEDICAL ADVANCED RESEARCH AND DEVELOP- MENT AUTHORITY AND THE BIOSHIELD SPECIAL RESERVE  FUND.  (a) BIOSHIELD SPECIAL RESERVE FUND.—Section 319F–2(g)(1)  (42 U.S.C. 247d–6b(g)(1)) is amended—  (1) by striking ‘‘$2,800,000,000 for the period of fiscal years  2014 through 2018’’ and inserting ‘‘$7,100,000,000 for the period  of fiscal years 2019 through 2028, to remain available until  expended’’; and  (2) by striking the second sentence.  (b) THE BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT  AUTHORITY.—Section 319L(d)(2) (42 U.S.C. 247d–7e(d)(2)) is  amended by striking ‘‘$415,000,000 for each of fiscal years 2014  through 2018’’ and inserting ‘‘$611,700,000 for each of fiscal years  2019 through 2023’’.  (a) ADVISORY COUNCIL.—The Secretary of Health and Human  Services (referred to in this section as the ‘‘Secretary’’) may continue  the Presidential Advisory Council on Combating Antibiotic-Resist- ant Bacteria, referred to in this section as the ‘‘Advisory Council’’.  (b) DUTIES.—The Advisory Council shall advise and provide  information and recommendations to the Secretary regarding pro- grams and policies intended to reduce or combat antibiotic-resistant  Recommenda-  tions.  Continuation.  42 USC 247d–5  note. 